应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MACK Merrimack Pharmaceuticals
盘前交易 07-17 04:42:41 EDT
15.13
+0.00
0.00%
最高
15.13
最低
15.13
成交量
0.00
今开
15.13
昨收
15.13
日振幅
0.00%
总市值
2.24亿
流通市值
1.45亿
总股本
1,479万
成交额
0.00
换手率
0.00%
流通股本
957.29万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Merrimack Pharmaceuticals(MACK.US):2024年Q1财报实现营收0美元,前值为0美元;每股收益为-0.03美元,前值为-0.02美元。
智通财经 · 05-16
Merrimack Pharmaceuticals(MACK.US):2024年Q1财报实现营收0美元,前值为0美元;每股收益为-0.03美元,前值为-0.02美元。
Merrimack Pharmaceuticals Inc盘中异动 快速拉升6.36%
自选股智能写手 · 02-14
Merrimack Pharmaceuticals Inc盘中异动 快速拉升6.36%
暂无数据
公司概况
公司名称:
Merrimack Pharmaceuticals
所属市场:
NASDAQ
上市日期:
--
主营业务:
Merrimack Pharmaceuticals, Inc.是一家生物制药公司,从事于商业化创新药物(包括搭配伴随诊断新型疗法)的发现、开发和准备。该公司有六个处于临床阶段的靶向治疗肿瘤的候选产品(MM-398,MM-121,MM-111,MM-302,MM-151和MM-141)和多个处于临床前开发阶段的候选产品,并致力于推动更多候选药物的发现。其研发工作是由网络生物学推动的,而网络生物学是以生物学为基础的用于生物医学研究的特殊学科。该公司于1993年在马萨诸塞联邦成立,于2010年10月在特拉华州重组。
发行价格:
--
{"stockData":{"symbol":"MACK","market":"US","secType":"STK","nameCN":"Merrimack Pharmaceuticals","latestPrice":15.13,"timestamp":1721160000000,"preClose":15.13,"halted":0,"volume":0,"delay":0,"floatShares":9572870,"shares":14788369,"eps":13.970311,"marketStatus":"盘前交易","marketStatusCode":1,"change":0,"latestTime":"07-17 04:42:41 EDT","open":15.13,"high":15.13,"low":15.13,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":13.970311,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721223000000},"adr":0,"listingDate":1332993600000,"adjPreClose":15.13,"adrRate":0,"dividendRate":0.132188,"volumeRatio":0,"impliedVol":0.7622,"impliedVolPercentile":0.8167},"requestUrl":"/m/hq/s/MACK/tweets","defaultTab":"tweets","newsList":[{"id":"2435462960","title":"Merrimack Pharmaceuticals(MACK.US):2024年Q1财报实现营收0美元,前值为0美元;每股收益为-0.03美元,前值为-0.02美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435462960","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435462960?lang=zh_cn&edition=full","pubTime":"2024-05-16 16:45","pubTimestamp":1715849127,"startTime":"0","endTime":"0","summary":"Merrimack Pharmaceuticals(MACK.US):2024年Q1财报实现营收0美元,前值为0美元;每股收益为-0.03美元,前值为-0.02美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405161645318b0e4037&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405161645318b0e4037&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MACK"],"gpt_icon":0},{"id":"2411398518","title":"Merrimack Pharmaceuticals Inc盘中异动 快速拉升6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411398518","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411398518?lang=zh_cn&edition=full","pubTime":"2024-02-14 02:10","pubTimestamp":1707847856,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日02时10分,Merrimack Pharmaceuticals Inc股票出现波动,股价大幅上涨6.36%。Merrimack Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为1.03%。Merrimack Pharmaceuticals Inc公司简介:Merrimack Pharmaceuticals Inc是一家生物技术公司,开发和销售是由具有诊断治疗癌症配对的新疗法的创新药物。Merrimack也签署了第三方协议,以进一步加工和商品化其产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214021056861d51bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214021056861d51bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MACK","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merrimack.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0307},{"period":"6month","weight":0.1506},{"period":"1year","weight":0.2888},{"period":"ytd","weight":0.1283}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Merrimack Pharmaceuticals, Inc.是一家生物制药公司,从事于商业化创新药物(包括搭配伴随诊断新型疗法)的发现、开发和准备。该公司有六个处于临床阶段的靶向治疗肿瘤的候选产品(MM-398,MM-121,MM-111,MM-302,MM-151和MM-141)和多个处于临床前开发阶段的候选产品,并致力于推动更多候选药物的发现。其研发工作是由网络生物学推动的,而网络生物学是以生物学为基础的用于生物医学研究的特殊学科。该公司于1993年在马萨诸塞联邦成立,于2010年10月在特拉华州重组。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.008904},{"month":2,"riseRate":0.5,"avgChangeRate":0.035174},{"month":3,"riseRate":0.666667,"avgChangeRate":0.015526},{"month":4,"riseRate":0.461538,"avgChangeRate":0.044098},{"month":5,"riseRate":0.461538,"avgChangeRate":-0.002858},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.038711},{"month":7,"riseRate":0.384615,"avgChangeRate":-0.049752},{"month":8,"riseRate":0.5,"avgChangeRate":-0.013029},{"month":9,"riseRate":0.5,"avgChangeRate":0.02556},{"month":10,"riseRate":0.25,"avgChangeRate":-0.116875},{"month":11,"riseRate":0.666667,"avgChangeRate":0.241275},{"month":12,"riseRate":0.333333,"avgChangeRate":0.031098}],"exchange":"NASDAQ","name":"Merrimack Pharmaceuticals","nameEN":"Merrimack Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Merrimack Pharmaceuticals(MACK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Merrimack Pharmaceuticals(MACK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Merrimack Pharmaceuticals,MACK,Merrimack Pharmaceuticals股票,Merrimack Pharmaceuticals股票老虎,Merrimack Pharmaceuticals股票老虎国际,Merrimack Pharmaceuticals行情,Merrimack Pharmaceuticals股票行情,Merrimack Pharmaceuticals股价,Merrimack Pharmaceuticals股市,Merrimack Pharmaceuticals股票价格,Merrimack Pharmaceuticals股票交易,Merrimack Pharmaceuticals股票购买,Merrimack Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Merrimack Pharmaceuticals(MACK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Merrimack Pharmaceuticals(MACK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}